| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,707 | 31,181 | 33,346 | 20,294 | | Cost of Revenue | 9,954 | 27,438 | 32,294 | 18,004 | | | Gross Profit | (5,247) | 3,743 | 1,052 | 2,290 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,613 | 1,671 | 2,811 | 3,001 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,860) | 2,072 | (1,759) | (711) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (156) | (184) | 7,051 | 2,490 | | Earnings Before Interest And Taxes | (7,016) | 1,888 | 5,292 | 1,779 | | Interest Expense | 971 | 1,122 | 1,258 | 2,079 | | Income Before Tax | (7,987) | 766 | 4,034 | (300) | | Income Tax Expense | (1,848) | 157 | 1,977 | (124) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,139) | 609 | 2,057 | (176) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,139) | 609 | 2,057 | (176) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,139) | $609 | $2,057 | ($176) |
|
0.51% Nasdaq 
Income Statement
